Jan 23 Reuters Johnson Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psoriasis drug Stelara, which is expected to face fresh U.S. competition from biosimilar versions next year. A key patent for Stelara expired in the United States last year, but JJ struck deals with competitors […]

Jan 23 Reuters Procter Gamble cut its annual profit forecast on Tuesday following a writedown in the value of its Gillette business in December and as the boost from earlier price hikes starts to fade in the United States. PG had said it would record a 1.3 billion charge related to a drop in the book […]